{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T05:10:33Z","timestamp":1792905033478,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.endien.2023.01.001","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T08:36:12Z","timestamp":1678178172000},"page":"116-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"S1","title":["Executive summary of the consensus document on hypophysitis of the Neuroendocrinology Area of Knowledge of the Spanish Society of Endocrinology and Nutrition"],"prefix":"10.1016","volume":"70","author":[{"given":"Pedro","family":"Iglesias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betina","family":"Biagetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Guerrero-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Cordido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J.","family":"D\u00edez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.endien.2023.01.001_bib0005","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00005792-198907000-00006","article-title":"Lymphocytic hypophysitis. Report of 3 new cases and review of the literature","volume":"68","author":"Cosman","year":"1989","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.endien.2023.01.001_bib0010","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJM199309023291002","article-title":"Lymphocytic infundibuloneurohypophysitis as a cause of central diabetes insipidus","volume":"329","author":"Imura","year":"1993","journal-title":"N Engl J Med."},{"key":"10.1016\/j.endien.2023.01.001_bib0015","first-page":"169","article-title":"[Lymphocytic infundibulo-hypophysitis with diabetes insipidus as a new clinical entity: a case report and review of the literature] Japanese","volume":"25","author":"Miyagi","year":"1997","journal-title":"No Shinkei Geka."},{"key":"10.1016\/j.endien.2023.01.001_bib0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF03343967","article-title":"Lymphocytic hypophysitis and diabetes insipidus in non-pregnant women","volume":"25","author":"Iglesias","year":"2002","journal-title":"J Endocrinol Invest."},{"key":"10.1016\/j.endien.2023.01.001_bib0025","series-title":"Endotext [Internet]","article-title":"Hypophysitis. 2021","author":"Prete","year":"2000"},{"key":"10.1016\/j.endien.2023.01.001_bib0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/clinem\/dgab672","article-title":"Hypophysitis, the growing spectrum of a rare pituitary disease","volume":"107","author":"Langlois","year":"2022","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endien.2023.01.001_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.101371","article-title":"Hypophysitis: an update on the novel forms, diagnosis and management of disorders of pituitary inflammation","volume":"33","author":"Gubbi","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"10.1016\/j.endien.2023.01.001_bib0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11102-021-01180-1","article-title":"Typing of inflammatory lesions of the pituitary","volume":"25","author":"Warmbier","year":"2022","journal-title":"Pituitary."},{"key":"10.1016\/j.endien.2023.01.001_bib0045","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.tem.2019.06.004","article-title":"The changing clinical spectrum of hypophysitis","volume":"30","author":"Chiloiro","year":"2019","journal-title":"Trends Endocrinol Metab."},{"key":"10.1016\/j.endien.2023.01.001_bib0050","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11154-018-9480-1","article-title":"Primary hypophysitis and other autoimmune disorders of the sellar and suprasellar regions","volume":"19","author":"Gubbi","year":"2018","journal-title":"Rev Endocr Metab Disord."},{"key":"10.1016\/j.endien.2023.01.001_bib0055","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an Endocrine Society Clinical Practice Guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endien.2023.01.001_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2021.104076","article-title":"Hypophysitis: a comprehensive overview","volume":"50","author":"de Vries","year":"2021","journal-title":"Presse Med."},{"key":"10.1016\/j.endien.2023.01.001_bib0065","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S2352-4642(21)00088-2","article-title":"Management of children and young people with idiopathic pituitary stalk thickening, central diabetes insipidus, or both: a national clinical practice consensus guideline","volume":"5","author":"Cerbone","year":"2021","journal-title":"Lancet Child Adolesc Health."},{"key":"10.1016\/j.endien.2023.01.001_bib0070","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11547-019-01120-x","article-title":"Imaging findings in hypophysitis: a review","volume":"125","author":"Caranci","year":"2020","journal-title":"Radiol Med."},{"key":"10.1016\/j.endien.2023.01.001_bib0075","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s11102-016-0736-z","article-title":"Revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects","volume":"19","author":"Bellastella","year":"2016","journal-title":"Pituitary."},{"key":"10.1016\/j.endien.2023.01.001_bib0080","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3171\/jns.2004.101.2.0262","article-title":"Primary hypophysitis: a single-center experience in 16 cases","volume":"101","author":"Leung","year":"2004","journal-title":"J Neurosurg."},{"key":"10.1016\/j.endien.2023.01.001_bib0085","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1530\/EJE-17-0009","article-title":"Mechanisms in endocrinology: hypophysitis: diagnosis and treatment","volume":"179","author":"Joshi","year":"2018","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.endien.2023.01.001_bib0090","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.clineuro.2014.06.011","article-title":"Ipilimumab treatment associated pituitary hypophysitis: clinical presentation and imaging diagnosis","volume":"125","author":"Chodakiewitz","year":"2014","journal-title":"Clin Neurol Neurosurg."},{"key":"10.1016\/j.endien.2023.01.001_bib0095","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s12149-015-0969-3","article-title":"Role of F-18 FDG PET\/CT in assessing IgG4-related disease with inflammation of head and neck glands","volume":"29","author":"Tokue","year":"2015","journal-title":"Ann Nucl Med."},{"key":"10.1016\/j.endien.2023.01.001_bib0100","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s12149-012-0635-y","article-title":"The usefulness of F-18 fluorodeoxyglucose positron emission tomography\/computed tomography in patients with Langerhans cell histiocytosis","volume":"26","author":"Lee","year":"2012","journal-title":"Ann Nucl Med."},{"key":"10.1016\/j.endien.2023.01.001_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.04.010","article-title":"New causes of hypophysitis","volume":"33","author":"Yuen","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"10.1016\/j.endien.2023.01.001_bib0110","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/er.2004-0011","article-title":"Autoimmune hypophysitis","volume":"26","author":"Caturegli","year":"2005","journal-title":"Endocr Rev."},{"key":"10.1016\/j.endien.2023.01.001_bib0115","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/EJE-13-0642","article-title":"The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and\/or central diabetes insipidus and review of the literature","volume":"170","author":"Bando","year":"2013","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.endien.2023.01.001_bib0120","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol."},{"key":"10.1016\/j.endien.2023.01.001_bib0125","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11102-022-01213-3","article-title":"Discrimination between non-functioning pituitary adenomas and hypophysitis using machine learning methods based on magnetic resonance imaging-derived texture features","volume":"25","author":"Sahin","year":"2022","journal-title":"Pituitary."},{"key":"10.1016\/j.endien.2023.01.001_bib0130","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s11102-022-01232-0","article-title":"Preoperative differentiation of hypophysitis and pituitary adenomas using a novel clinicoradiologic scoring system","volume":"25","author":"Wright","year":"2022","journal-title":"Pituitary."},{"key":"10.1016\/j.endien.2023.01.001_bib0135","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-22-0689","article-title":"Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline","volume":"187","author":"Husebye","year":"2022","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.endien.2023.01.001_bib0140","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1210\/jc.2015-2146","article-title":"Treatment of primary hypophysitis in Germany","volume":"100","author":"Honegger","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endien.2023.01.001_bib0145","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1530\/eje.1.02183","article-title":"Primary hypophysitis: clinical-pathological correlations","volume":"155","author":"Gutenberg","year":"2006","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.endien.2023.01.001_bib0150","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/a-1163-7304","article-title":"Clinical characteristics of primary hypophysitis \u2013 a single-centre series of 60 cases","volume":"129","author":"Amereller","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes."},{"key":"10.1016\/j.endien.2023.01.001_bib0155","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1210\/jcem.85.4.6501","article-title":"Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment","volume":"85","author":"Kaltsas","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endien.2023.01.001_bib0160","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/qjmed\/hcs121","article-title":"Hypothalamo-pituitary sarcoidosis: a multicenter study of 24 patients","volume":"105","author":"Langrand","year":"2012","journal-title":"QJM."},{"key":"10.1016\/j.endien.2023.01.001_bib0165","first-page":"e245","article-title":"Diagnosis and treatment of autoimmune hypophysitis: a short review","volume":"34","author":"Lupi","year":"2011","journal-title":"J Endocrinol Invest."},{"key":"10.1016\/j.endien.2023.01.001_bib0170","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1210\/jc.2014-2306","article-title":"Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma","volume":"99","author":"Faje","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endien.2023.01.001_bib0175","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1530\/EJE-17-0123","article-title":"Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis","volume":"177","author":"Lupi","year":"2017","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.endien.2023.01.001_bib0180","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/cen.13354","article-title":"Primary lymphocytic hypophysitis: Clinical characteristics and treatment of 50 cases in a single centre in China over 18 years","volume":"87","author":"Wang","year":"2017","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.1016\/j.endien.2023.01.001_bib0185","doi-asserted-by":"crossref","first-page":"47","DOI":"10.20945\/2359-3997000000102","article-title":"Clinical and hormonal characteristics of patients with different types of hypophysitis: a single-center experience","volume":"63","author":"Imga","year":"2019","journal-title":"Arch Endocrinol Metab."},{"key":"10.1016\/j.endien.2023.01.001_bib0190","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/07435800.2020.1817064","article-title":"Primary and ipilimumab-induced hypophysitis: a single-center case series","volume":"45","author":"Atkins","year":"2020","journal-title":"Endocr Res."},{"key":"10.1016\/j.endien.2023.01.001_bib0195","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/a-0919-4388","article-title":"Primary hypophysitis: experience of a single tertiary center","volume":"129","author":"Korkmaz","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes."},{"key":"10.1016\/j.endien.2023.01.001_bib0200","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000516006","article-title":"Early pulse glucocorticoid therapy and improved hormonal outcomes in primary hypophysitis","volume":"112","author":"Krishnappa","year":"2022","journal-title":"Neuroendocrinology."},{"key":"10.1016\/j.endien.2023.01.001_bib0205","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1210\/clinem\/dgab839","article-title":"Outcomes of initial management strategies in patients with autoimmune lymphocytic hypophysitis: a systematic review and meta-analysis","volume":"107","author":"Donegan","year":"2022","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endien.2023.01.001_bib0210","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1210\/jc.2018-01021","article-title":"Hypophysitis outcome and factors predicting responsiveness to glucocorticoid therapy: a prospective and double-arm study","volume":"103","author":"Chiloiro","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endien.2023.01.001_bib0215","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.3171\/2012.2.JNS111456","article-title":"Novel strategy to treat a case of recurrent lymphocytic hypophysitis using rituximab","volume":"116","author":"Schreckinger","year":"2012","journal-title":"J Neurosurg."},{"key":"10.1016\/j.endien.2023.01.001_bib0220","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximab for IgG4-related disease: a prospective, open-label trial","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.endien.2023.01.001_bib0225","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5382640","article-title":"Clinical characteristics of 76 patients with IgG4-related hypophysitis: a systematic literature review","volume":"2019","author":"Li","year":"2019","journal-title":"Int J Endocrinol."},{"key":"10.1016\/j.endien.2023.01.001_bib0230","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3171\/2009.6.JNS081176","article-title":"Gamma knife surgery for lymphocytic hypophysitis","volume":"112","author":"Ray","year":"2010","journal-title":"J Neurosurg."},{"key":"10.1016\/j.endien.2023.01.001_bib0235","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-0037-1604079","article-title":"Lymphocytic hypophysitis successfully treated with stereotactic radiosurgery: case report and review of the literature","volume":"79","author":"Pekic","year":"2018","journal-title":"J Neurol Surg A Cent Eur Neurosurg."},{"key":"10.1016\/j.endien.2023.01.001_bib0240","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/art.39132","article-title":"International Consensus Guidance statement on the management and treatment of IgG4-related disease","volume":"67","author":"Khosroshahi","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"suppl_4","key":"10.1016\/j.endien.2023.01.001_bib0245","doi-asserted-by":"crossref","first-page":"iv119","DOI":"10.1093\/annonc\/mdx225","article-title":"Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Haanen","year":"2017","journal-title":"Ann Oncol."},{"key":"10.1016\/j.endien.2023.01.001_bib0250","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1200\/JCO.2017.77.6385","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical Practice Guideline","volume":"36","author":"Brahmer","year":"2018","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.endien.2023.01.001_bib0255","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pky021","article-title":"The current understanding of the endocrine effects from immune checkpoint inhibitors and recommendations for management","volume":"2","author":"Girotra","year":"2018","journal-title":"JNCI Cancer Spectr."},{"key":"10.1016\/j.endien.2023.01.001_bib0260","doi-asserted-by":"crossref","first-page":"9551","DOI":"10.2147\/CMAR.S224791","article-title":"Managing ipilimumab-induced hypophysitis: challenges and current therapeutic strategies","volume":"12","author":"Tsoli","year":"2020","journal-title":"Cancer Manag Res."},{"key":"10.1016\/j.endien.2023.01.001_bib0265","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ando.2018.07.008","article-title":"Expert opinion on pituitary complications in immunotherapy","volume":"79","author":"Briet","year":"2018","journal-title":"Ann Endocrinol (Paris)."},{"key":"10.1016\/j.endien.2023.01.001_bib0270","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/ERC-18-0320","article-title":"French Endocrine Society Guidance on endocrine side effects of immunotherapy","volume":"26","author":"Castinetti","year":"2019","journal-title":"Endocr Relat Cancer."},{"key":"10.1016\/j.endien.2023.01.001_bib0275","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00296-019-04338-0","article-title":"Pituitary involvement in patients with granulomatosis with polyangiitis: case series and literature review","volume":"39","author":"Gu","year":"2019","journal-title":"Rheumatol Int."},{"key":"10.1016\/j.endien.2023.01.001_bib0280","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10067-019-04735-7","article-title":"Pituitary dysfunction in granulomatosis with polyangiitis","volume":"39","author":"Vega-Beyhart","year":"2020","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.endien.2023.01.001_bib0285","doi-asserted-by":"crossref","first-page":"391","DOI":"10.12659\/AJCR.903233","article-title":"Primary pituitary tuberculosis revisited","volume":"18","author":"Ben Abid","year":"2017","journal-title":"Am J Case Rep."},{"key":"10.1016\/j.endien.2023.01.001_bib0290","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/1471-2334-13-481","article-title":"Acute hypophysitis and hypopituitarism in early syphilitic meningitis in a HIV-infected patient: a case report","volume":"13","author":"Spinner","year":"2013","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.endien.2023.01.001_bib0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2015.04.071","article-title":"Intracranial toxoplasmosis presenting as panhypopituitarism in an immunocompromised patient","volume":"33","author":"Hamdeh","year":"2015","journal-title":"Am J Emerg Med."},{"key":"10.1016\/j.endien.2023.01.001_bib0300","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1210\/jc.2015-2049","article-title":"The great imitator in endocrinology: a painful hypophysitis mimicking a pituitary tumor","volume":"100","author":"Bricaire","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endien.2023.01.001_bib0305","doi-asserted-by":"crossref","first-page":"e2649","DOI":"10.1210\/clinem\/dgac025","article-title":"Letter to the Editor from Asa and Mete: \u201cHypophysitis, the growing spectrum of a rare pituitary disease\u201d","volume":"107","author":"Asa","year":"2022","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endien.2023.01.001_bib0310","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1016\/j.clml.2020.08.007","article-title":"Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic Lymphohistiocytosis","volume":"21","author":"Salama","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.endien.2023.01.001_bib0315","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s40618-016-0451-7","article-title":"Endocrine dysfunction in hereditary hemochromatosis","volume":"39","author":"Pelusi","year":"2016","journal-title":"J Endocrinol Invest."},{"key":"10.1016\/j.endien.2023.01.001_bib0320","article-title":"Hypopituitarism in Wilson\u2019s disease resolved after copper-chelating therapy","volume":"2021","author":"Dauth","year":"2021","journal-title":"Endocrinol Diabetes Metab Case Rep."},{"key":"10.1016\/j.endien.2023.01.001_bib0325","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s11102-016-0773-7","article-title":"Critical review of IgG4-related hypophysitis","volume":"20","author":"Shikuma","year":"2017","journal-title":"Pituitary."},{"key":"10.1016\/j.endien.2023.01.001_bib0330","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa048","article-title":"A case series of patients with isolated IgG4-related hypophysitis treated with rituximab","volume":"4","author":"Boharoon","year":"2020","journal-title":"J Endocr Soc."},{"key":"10.1016\/j.endien.2023.01.001_bib0335","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnz003","article-title":"Autoimmune pituitary disease: new concepts with clinical implications","volume":"41","author":"Yamamoto","year":"2020","journal-title":"Endocr Rev."},{"key":"10.1016\/j.endien.2023.01.001_bib0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2021.101601","article-title":"Paraneoplastic autoimmune hypophysitis: an emerging concept","volume":"36","author":"Bando","year":"2022","journal-title":"Best Pract Res Clin Endocrinol Metab."}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018023000379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018023000379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:17:26Z","timestamp":1762867046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530018023000379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":68,"alternative-id":["S2530018023000379"],"URL":"https:\/\/doi.org\/10.1016\/j.endien.2023.01.001","relation":{},"ISSN":["2530-0180"],"issn-type":[{"value":"2530-0180","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Executive summary of the consensus document on hypophysitis of the Neuroendocrinology Area of Knowledge of the Spanish Society of Endocrinology and Nutrition","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endien.2023.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.endinu.2023.01.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 SEEN and SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}